(NASDAQ: IMNN), a clinical-stage company focused on developing non-viral DNA-mediated immunotherapy and evaluating an adaptation of the platform’s potential as a next-generation vaccine, today ...

The following is a summary of “Biomarker states and risk of death among individuals hospitalized with SARS-CoV-2 infection,” published in the February 2025 issue of BMC Infectious Diseases by ...

Scientists at the Wuhan Institute of Virology in China have discovered a new lineage of a coronavirus in bats that can enter ...